Haisco Pharmaceutical Group (002653.SZ) released the third quarter report for 2024, achieving revenue of 2...
According to the Zhitong Finance APP, Haisco Pharmaceutical Group (002653.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 2.751 billion yuan, a year-on-year increase of 15.41%. The net income attributable to shareholders of the listed company was 0.382 billion yuan, an increase of 90.20% year-on-year. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.215 billion yuan, an increase of 44.55% year-on-year.
